Prof. Gil Westmeyer and Kilian Vogele (IMAGE) Technical University of Munich (TUM) Caption Prof. Gil Westmeyer (l.) and his research team, in collaboration with Kilian Vogele (r.) and the start-up Invitris, have developed a new controlled production method to create bacteriophages for therapeutic use. Credit A. Heddergott / TUM Usage Restrictions Free for use on reporting on TUM with copyright noted. License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.